Drug intelligence / Profile preview

Ocuguard

Development stage
Unknown
Lead developer
Orchidia Pharma
Modality
Small Molecules
Administration
Oral
01

Overview

Ocuguard is a multi-ingredient nutritional supplement developed and manufactured by Orchidia Pharmaceutical, primarily for the Egyptian market. It is formulated as oral soft gelatin capsules designed to support ocular and neural health, particularly in patients with diabetic retinopathy or age-related macular degeneration (AMD). The standard Ocuguard formulation contains Ginkgo biloba leaf extract (40 mg), which is intended to improve ocular microcirculation and provide neuroprotection, alongside a suite of antioxidants including Vitamin C, Nicotinamide (Vitamin B3), Vitamin B12, Beta Carotene, Vitamin E, Selenium, and Zinc. A variant, Ocuguard LX, focuses on macular health by incorporating Lutein and Zeaxanthin. Although some clinical databases may misclassify this product as a topical ophthalmic medication, it is commercially available only as an oral supplement.

Brand names
OcuguardOcuguard LX

Beyond the preview

Go deeper on Ocuguard.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ocuguard.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call